Heidelberg Pharma AG's market cap is currently €161.32M. The company's EPS TTM is €; its P/E ratio is ―; Heidelberg Pharma AG is scheduled to report earnings on July 10, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
